Harbor BioSciences Apoptone(R) for Prostate Cancer Shows Activity at All Doses Tested
June 07, 2010 14:19 ET
|
Harbor BioSciences, Inc.
CHICAGO, June 7, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today presented new positive data from its ongoing Phase I/IIa clinical trial with Apoptone® (HE3235) for...
Harbor BioSciences Announces $2.06 Million Equity Financing
June 07, 2010 08:44 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, June 7, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) announced today that it has entered into an agreement with certain institutional investors to raise approximately...
Harbor BioSciences Apoptone(R) Clinical Results Poster Selected for ASCO Annual Meeting
May 17, 2010 08:00 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, May 17, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today announced that new data from the Phase I/IIa clinical trial of the company's lead drug candidate...
Triolex(R) Demonstrates Evidence of Anti-Inflammatory Activity in a Phase IIa Clinical Trial in a Subset of Type 2 Diabetes Mellitus Patients
May 10, 2010 08:00 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, May 10, 2010 (GLOBE NEWSWIRE) -- Harbor Biosciences (Nasdaq:HRBR), a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
Harbor BioSciences Announces Listing Transfer to The Nasdaq Capital Market
March 17, 2010 16:30 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, March 17, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today announced that NASDAQ has approved its application to transfer its stock listing to The Nasdaq Capital Market...
Harbor BioSciences Reports New Phase I/IIa Data at ASCO Symposium and Announces Plans to Advance Prostate Cancer Treatment Apoptone(R) to Phase IIb
March 08, 2010 08:00 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, March 8, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences Inc. (Nasdaq:HRBR) said today it had reported encouraging data from its ongoing Phase I/IIa clinical trial with Apoptone® (HE3235)...
Harbor BioSciences to Present Results on Lead Drug Candidate Apoptone(R)
March 01, 2010 08:30 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, March 1, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today announced it will present a poster at the ASCO Genitourinary Cancers Symposium in San Francisco this week,...